HIQ Stock Overview
Engages in development and commercialization of concussion management technology and software in Australia. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
HITIQ Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.039 |
| 52 Week High | AU$0.042 |
| 52 Week Low | AU$0.013 |
| Beta | 0.21 |
| 11 Month Change | 69.57% |
| 3 Month Change | 129.41% |
| 1 Year Change | 116.67% |
| 33 Year Change | -75.62% |
| 5 Year Change | n/a |
| Change since IPO | -83.75% |
Recent News & Updates
Recent updates
Shareholder Returns
| HIQ | AU Healthcare Services | AU Market | |
|---|---|---|---|
| 7D | 0% | 8.8% | 1.2% |
| 1Y | 116.7% | 137.0% | 19.7% |
Return vs Industry: HIQ underperformed the Australian Healthcare Services industry which returned 137% over the past year.
Return vs Market: HIQ exceeded the Australian Market which returned 19.7% over the past year.
Price Volatility
| HIQ volatility | |
|---|---|
| HIQ Average Weekly Movement | 27.5% |
| Healthcare Services Industry Average Movement | 9.2% |
| Market Average Movement | 8.6% |
| 10% most volatile stocks in AU Market | 17.5% |
| 10% least volatile stocks in AU Market | 3.2% |
Stable Share Price: HIQ's share price has been volatile over the past 3 months compared to the Australian market.
Volatility Over Time: HIQ's weekly volatility (27%) has been stable over the past year, but is still higher than 75% of Australian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2015 | 25 | Mike Vegar | www.hitiq.com |
HITIQ Limited, together with its subsidiaries, engages in development and commercialization of concussion management technology and software in Australia. The company offers Smart Mouthguard, a mouthguard embedded with sensor technology to measure head impact events; and Nexus, a calibrated mouthguard with impact sensors that captures the frequency, location, and intensity of head impact exposures. It also provides CSX platform, a sideline concussion assessment tool that produces a digital record that can be shared with medical professionals, family, and organizations to ensure coordinated athlete care; CoVR, a virtual reality based cognitive and oculomotor assessment platform; and ConneQt, an integrated ecosystem linking team administrators, caregivers, and players to medical professionals.
HITIQ Limited Fundamentals Summary
| HIQ fundamental statistics | |
|---|---|
| Market cap | AU$14.51m |
| Earnings (TTM) | -AU$3.20m |
| Revenue (TTM) | AU$4.75m |
3.1x
P/S Ratio-4.5x
P/E RatioIs HIQ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HIQ income statement (TTM) | |
|---|---|
| Revenue | AU$4.75m |
| Cost of Revenue | AU$4.41m |
| Gross Profit | AU$334.64k |
| Other Expenses | AU$3.54m |
| Earnings | -AU$3.20m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0091 |
| Gross Margin | 7.05% |
| Net Profit Margin | -67.48% |
| Debt/Equity Ratio | -191.4% |
How did HIQ perform over the long term?
See historical performance and comparison